Skip to content

US · XXII · TOBACCO

22nd Century Group, Inc. (XXII) intrinsic value and stock valuation

$0.34as of 2026-11-21 · Mkt cap 1.5M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

22nd Century Group, Inc. DCF and intrinsic value

InvestorsCraft values XXII with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from XXII’s statements →

22nd Century Group, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Consumer Defensive · Tobacco Mocksville, NY 27028 xxiicentury.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$7.05M-24.2% 5y CAGRd
20112025
Net income
-$-5.05M
20112025
Free cash flow
-$-8.6M
20112025
Total equity
$15.8M-18.6% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$7.05M$11.9M$32.2M$40.5M$31M
Operating income-$-11.42M-$-13.95M-$-44.93M-$-33.63M-$-28.41M
Net income-$-5.05M-$-15.16M-$-140.78M-$-59.8M-$-32.61M
EPSd-$-28.06M————
Operating cash flow-$-7.72M-$-14.35M-$-54.99M-$-51.71M-$-22.84M
Capital expenditure-$-880K-$-160K-$-5.62M-$-4.43M-$-1.07M
Free cash flow-$-8.6M-$-14.51M-$-60.6M-$-56.14M-$-23.91M
Total assets$27M$21.7M$27.5M$114.7M$76M
Total debt$4.21M$8.62M$16.4M$4.65M$2.34M
Net debt-$-2.94M$4.2M$14.3M$2.45M$1M
Total equity$15.8M$4.01M-$-8.41M$96M$66.1M
Cash and short-term investments$7.15M$4.42M$2.06M$20.4M$48.7M
Income statement
20252024202320222021
Revenue$7.05M$11.9M$32.2M$40.5M$31M
Cost of revenue$10.2M$14.3M$40.9M$38.7M$29.5M
Gross profit-$-3.14M-$-2.4M-$-8.7M$1.85M$1.49M
Research and development expenses$690K$1.13M$2.64M$3.58M$3.91M
Selling, general and administrative expenses$7.59M$10.3M$31.8M$32.2M$25.9M
Other expenses$0.00$130K$1.76M-$-330K$80K
Operating expenses$8.28M$11.6M$36.2M$35.5M$29.9M
Cost and expenses$18.5M$25.8M$77.1M$74.1M$59.4M
Interest income$80K$70K$220K$310K$320K
Interest expense$1.46M$2.09M$9.37M$60K$60K
Depreciation and amortization$1.16M$1.26M$4.86M$3.59M$1.54M
Ebitda-$-10.53M-$-12.11M-$-40.41M-$-32.89M-$-31M
Operating income-$-11.42M-$-13.95M-$-44.93M-$-33.63M-$-28.41M
Total other income/expenses, net-$-1.73M-$-1.51M-$-9.71M-$-2.9M-$-4.18M
Income before tax-$-13.14M-$-15.46M-$-54.64M-$-36.53M-$-32.59M
Income tax expense-$-30K$30K$50K$20K$10K
Net income-$-5.05M-$-15.16M-$-140.78M-$-59.8M-$-32.61M
Weighted average shares outstanding$180K$0.00$0.00$0.00$0.00
Weighted average diluted shares outstanding$180K$0.00$0.00$0.00$0.00
Balance sheet
20252024202320222021
Cash and short-term investments$7.15M$4.42M$2.06M$20.4M$48.7M
Net receivables$3.59M$2.2M$1.67M$1.36M$580K
Inventory$4.33M$2.02M$4.35M$7.27M$2.88M
Total current assets$17.6M$11.5M$16.3M$44.6M$54.4M
Property, plant and equipment, net$3.17M$4.41M$5.29M$4.63M$7.56M
Goodwill and intangible assets$4.02M$5.72M$5.92M$7.21M$7.92M
Long-term investments$0.00$0.00$0.00$680K$2.35M
Total non-current assets$9.39M$10.2M$11.2M$70.1M$21.6M
Total assets$27M$21.7M$27.5M$114.7M$76M
Accounts payable$1M$2.4M$4.45M$2.05M$2.17M
Short-term debt$370K$2.02M$6.62M$940K$900K
Deferred revenue$1.72M$20K$730K$690K$120K
Total current liabilities$7.27M$9.96M$25M$13M$8.43M
Long-term debt$3.84M$6.6M$9.76M$3.71M$1.43M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$3.99M$7.7M$10.9M$5.66M$1.45M
Capital lease obligations$600K$1.7M$1.93M$960K$1.74M
Total liabilities$11.3M$17.7M$35.9M$18.7M$9.88M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-398.93M-$-393.87M-$-378.71M-$-237.81M-$-178.01M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00-$-110K-$-160K
Total equity$15.8M$4.01M-$-8.41M$96M$66.1M
Total investments$0.00$0.00$0.00$18.9M$49.7M
Total debt$4.21M$8.62M$16.4M$4.65M$2.34M
Net debt-$-2.94M$4.2M$14.3M$2.45M$1M
Cash flow statement
20252024202320222021
Net income-$-5.05M-$-15.16M-$-140.78M-$-59.8M-$-32.61M
Depreciation and amortization$1.16M$1.26M$4.86M$3.59M$1.54M
Stock-based compensation$420K$380K$2.68M$5.49M$3.98M
Change in working capital-$-6.57M$3.17M-$-1.74M-$-11.57M-$-730K
Accounts receivable-$-1.88M-$-30K-$-20K-$-2.88M$1.57M
Inventory-$-2.05M$6.71M-$-5.92M-$-8.79M-$-1.16M
Accounts payable-$-2.66M-$-1.17M$4.75M$420K$10K
Net cash provided by operating activities-$-7.72M-$-14.35M-$-54.99M-$-51.71M-$-22.84M
Investments in property, plant and equipment-$-60K-$-140K-$-4.66M-$-4.43M-$-1.07M
Acquisitions, net$0.00$0.00$410K-$-1.98M$330K
Net cash used for investing activities-$-510K-$-140K$16.8M$22.6M-$-27.73M
Common stock issued$5.08M$16.1M$27.9M$35M$40M
Common stock repurchased$0.00$0.00-$-180K$0.00$0.00
Dividends paid$0.00-$-10.3M$0.00$0.00$0.00
Net cash used for financing activities$11M$16.9M$37.2M$30.8M$50.9M
Net change in cash$2.73M$2.36M-$-960K$1.68M$310K
Cash at end of period$7.15M$4.42M$2.06M$3.02M$1.34M
Operating cash flow-$-7.72M-$-14.35M-$-54.99M-$-51.71M-$-22.84M
Capital expenditure-$-880K-$-160K-$-5.62M-$-4.43M-$-1.07M
Free cash flow-$-8.6M-$-14.51M-$-60.6M-$-56.14M-$-23.91M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About 22nd Century Group, Inc.

        22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

        CEO
        Lawrence D. Firestone
        Employees
        32
        Beta
        0.67

        Explore

        Frequently asked questions

        What is the intrinsic value of 22nd Century Group, Inc. (XXII)?

        InvestorsCraft does not currently publish an intrinsic value for XXII. How the IC value is calculated.

        Is XXII undervalued?

        InvestorsCraft does not publish an undervaluation signal for XXII at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.